E-LIB Suche - Ergebnisse für: Johnell, O.

1

Rehabilitation of hip fracture patients with Parkinson's Di..:

Jónsson, B ; Sernbo, I ; Johnell, O
Journal of Rehabilitation Medicine. 27 (2020) 4 - p. 227-230 , 2020

Link: https://doi.org/10.2340/..

2

BMD, clinical risk factors and their combination for hip fr..:

Johansson, H. ; Kanis, J. A. ; Oden, A...
Osteoporosis International. 20 (2009) 10 - p. 1675-1682 , 2009

Link: https://doi.org/10.1007/..

3

Validation of the IOF quality of life questionnaire for pat..:

Working Group for Quality of Life of the International Osteoporosis Foundation ; Lips, P. ; Jameson, K....
Osteoporosis International. 21 (2009) 1 - p. 61-70 , 2009

Link: https://doi.org/10.1007/..

4

FRAX I OTsENKA RISKA PERELOMA U MUZhChIN I ZhENShchIN V VEL..:

KANNIS, J. A. ; JOHNELL, O ; ODEN, A..
Osteoporosis and Bone Diseases. 11 (2008) 2 - p. 38-44 , 2008

Link: https://doi.org/10.14341..

5

FRAX™ and the assessment of fracture probability in men and..:

Kanis, J. A. ; Johnell, O. ; Oden, A...
Osteoporosis International. 19 (2008) 4 - p. 385-397 , 2008

Link: https://doi.org/10.1007/..

6

"Reprint of" A longitudinal study of the perimenopausal tra..:

Rannevik, G. ; Jeppsson, S. ; Johnell, O....
Maturitas. 61 (2008) 1-2 - p. 67-77 , 2008

Link: https://doi.org/10.1016/..

7

Cost-effectiveness of alendronate in the treatment of postm..:

Ström, O. ; Borgström, F. ; Sen, S. S....
Osteoporosis International. 18 (2007) 8 - p. 1047-1061 , 2007

Link: https://doi.org/10.1007/..

8

The use of clinical risk factors enhances the performance o..:

Kanis, J. A. ; Oden, A. ; Johnell, O....
Osteoporosis International. 18 (2007) 8 - p. 1033-1046 , 2007

Link: https://doi.org/10.1007/..

9

Kyphoplastie vs traitement conventionnel du tassement verté..:

Mazières, B. ; Van Meirhaeghe, J. ; Johnell, O....
Revue du Rhumatisme. 73 (2006) 10-11 - p. 1057-1058 , 2006

Link: https://doi.org/10.1016/..

10

The cost-effectiveness of risedronate in the treatment of o..:

Borgström, F. ; Carlsson, Å. ; Sintonen, H....
Osteoporosis International. 17 (2006) 7 - p. 996-1007 , 2006

Link: https://doi.org/10.1007/..

11

SHBG Gene Promoter Polymorphisms in Men Are Associated with..:

Eriksson, A. L. ; Lorentzon, M. ; Mellström, D....
The Journal of Clinical Endocrinology & Metabolism. 91 (2006) 12 - p. 5029-5037 , 2006

Link: https://doi.org/10.1210/..

12

INSULIN, OESTROGEN AND LEAN BODY MASS - THREE RISK FACTORS ..:

Hammarsten, J. ; Damber, J.E. ; Johnell, O....
European Urology Supplements. 5 (2006) 2 - p. 121 , 2006

Link: https://doi.org/10.1016/..

13

PD-02.03:

Hammarsten, J. ; Damber, J.-E. ; Johnell, O....
Urology. 68 (2006) - p. 5 , 2006

Link: https://doi.org/10.1016/..

14

Whom to treat? The contribution of vertebral X-rays to risk..:

Kaptoge, S. ; Armbrecht, G. ; Felsenberg, D....
Osteoporosis International. 17 (2006) 9 - p. 1369-1381 , 2006

Link: https://doi.org/10.1007/..

15

At what hip fracture risk is it cost-effective to treat?: I..:

Borgström, F. ; Johnell, O. ; Kanis, J. A...
Osteoporosis International. 17 (2006) 10 - p. 1459-1471 , 2006

Link: https://doi.org/10.1007/..